Skip to content
Screener

Carlsmed, Inc. CARL Debt-to-equity

Debt-to-equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
0.6×-0.1×
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
0.6×+0.2×
Globus Medical logo
Globus MedicalGMED
0.0×
Alphatec Holdings logo
Alphatec HoldingsATEC
48×
Medtronic logo
MedtronicMDT
0.6×0.0×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
3.4×+3.2×

Other financials

Income statement

See full
Revenue$18.9M+56.7%
Gross profit$14.5M+64.0%
Operating income-$11.0M-69.7%
Net income-$10.5M-55.3%
EPS (diluted)-$0.39+73.5%

Balance sheet

See full
Cash & equivalents$46.2M+38.2%
Total debt$21.9M+23.8%
Total equity$84.2M+201%
Total assets$118.2M+122%

Cash flow

See full
Operating cash flow-$7.4M-4.5%
CapEx$121.0K-63.0%
Free cash flow-$7.5M-1.5%

Valuation

See full
Market cap$377.32M+11.9%
Enterprise value$353M
P/S

Profitability

See full
Gross margin76.6%+2.6pp
Operating margin-61.1%-3.1pp
Net margin-57.4%-6.2pp
FCF margin-54.6%-10.6pp

Returns & leverage

See full
Return on equity-6,196.9%
Current ratio8.8×+4.0×

Where this comes from

Calculated from Carlsmed, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Carlsmed, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:10 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001794546-26-000016

FAQ

What is Carlsmed, Inc.'s debt-to-equity?
Carlsmed, Inc. (CARL) reported debt-to-equity of 0.3× in Q2 2026.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

Ask your AI about Carlsmed, Inc.'s debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude